Certara Acquires Vyasa Analytics
January 4, 2023
Certara, Inc. (Nasdaq: CERT) has acquired Vyasa Analytics, LLC to integrate Vyasa’s deep-learning platform LAYAR and AI capabilities into Certara’s biosimulation software suite. The acquisition expands Certara’s data fabric and AI-driven prediction capabilities to accelerate drug discovery and development.
- Buyers
- Certara, Inc.
- Targets
- Vyasa Analytics, LLC
- Industry
- AI & Machine Learning
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Certara Acquires Chemaxon to Expand Drug Discovery Software Capabilities
July 9, 2024
Software
Certara, Inc. has signed a definitive agreement to acquire Chemaxon, a leading cheminformatics software provider, with the transaction expected to close in the second half of 2024, subject to regulatory approvals. The acquisition adds Chemaxon’s discovery-focused cheminformatics tools to Certara’s biosimulation portfolio, enabling a more comprehensive data and predictive-analytics platform spanning discovery through development.
-
Certara Acquires Applied BioMath
December 14, 2023
Biotechnology
Certara, Inc. has acquired Applied BioMath to expand its biosimulation capabilities and establish the life sciences industry's largest quantitative systems pharmacology (QSP) center of excellence. The acquisition combines Certara's biosimulation and AI portfolios with Applied BioMath's proprietary QSP platform and modeling expertise to industrialize QSP and accelerate drug development.
-
Virtusa Acquires Sincera Technologies
July 25, 2025
IT Services
Virtusa Corporation has acquired Sincera Technologies, a software development and digital transformation firm focused on telecommunications, to strengthen Virtusa's AI, data and telecom transformation capabilities. The deal brings Sincera's 1Data platform and telecom domain expertise into Virtusa's digital engineering offerings to accelerate solutions for telecom and cable operators.
-
Nevro Corp. Acquires Vyrsa Technologies
November 30, 2023
Medical Devices
Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.
-
VeraScore Acquires Vala AI
February 26, 2025
Software
VeraScore, an AI-enabled financial health SaaS platform based in San Francisco, has acquired Seattle-based Vala AI in an equity deal. Vala AI's applied-AI software dependency and technical-debt management tools will be integrated into VeraScore's platform; Vala AI co-founder and CEO Christian Hammer will join VeraScore's board to support the integration and product expansion.
-
Cloudera Acquires Verta's Operational AI Platform
June 3, 2024
AI & Machine Learning
Cloudera has acquired Verta's Operational AI Platform and hired the Verta team into its machine learning organization to accelerate Cloudera's enterprise AI roadmap. The deal brings Verta's MLOps, model catalog and GenAI tooling into Cloudera's hybrid, multi-cloud data platform to strengthen operational AI, model governance, and developer tooling for customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.